SCHEMBL19251455

SCHEMBL19251455

CCCC(C)(C)c1cnc(NC)nc1

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.35
MAP4K4 O95819 1/20 0.33
PDE4A P27815 2/20 0.32
CNR2 P34972 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19251002 0.83 GRM5 (0.37) GRM5MAP4K4PDE4A
SCHEMBL18744472 0.79 CNR2 (0.33) CNR2
SCHEMBL18935596 0.78 NUDT1 (0.37) CNR2
SCHEMBL20878357 0.78 ESR1 (0.32) CNR2
SCHEMBL19069003 0.78 CNR2 (0.31) CNR2
SCHEMBL22752536 0.77 CNR2 (0.33) GRM5CNR2
SCHEMBL10202037 0.76 GRM5 (0.41) GRM5MAP4K4PDE4A
SCHEMBL23772094 0.75 PLK1 (0.34)
SCHEMBL22752323 0.74 CNR2 (0.33) CNR2
SCHEMBL19251175 0.74 CNR1 (0.33) CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9993554-B2 Use of P13K Inhibitors for the Treatment of Obesity, Steatosis and ageing CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS (CNIO) (ES) 2018-06-12 US disclosed
US-9732083-B2 Tricyclic gyrase inhibitors MERCK SHARP & DOHME CORP. (US) 2017-08-15 US disclosed